low dose aspirin

Generic: aspirin

Labeler: hy-vee
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name low dose aspirin
Generic Name aspirin
Labeler hy-vee
Dosage Form TABLET, COATED
Routes
ORAL
Active Ingredients

aspirin 81 mg/1

Manufacturer
Hy-Vee

Identifiers & Regulatory

Product NDC 42507-006
Product ID 42507-006_0915ffb3-ba95-4d9a-8bd1-c1401cc888dd
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M013
Marketing Start 2025-10-10
Marketing End 2027-01-01

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]
Physiologic Effect
decreased prostaglandin production [pe] decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 42507006
Hyphenated Format 42507-006

Supplemental Identifiers

RxCUI
308416
UPC
0075450825404
UNII
R16CO5Y76E
NUI
N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name low dose aspirin (source: ndc)
Generic Name aspirin (source: ndc)
Application Number M013 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 81 mg/1
source: ndc
Packaging
  • 1 BOTTLE, PLASTIC in 1 BOX (42507-006-12) / 120 TABLET, COATED in 1 BOTTLE, PLASTIC
  • 500 TABLET, COATED in 1 BOTTLE, PLASTIC (42507-006-50)
source: ndc

Packages (2)

42507-006-12 1 BOTTLE, PLASTIC in 1 BOX (42507-006-12) / 120 TABLET, COATED in 1 BOTTLE, PLASTIC 42507-006-50 500 TABLET, COATED in 1 BOTTLE, PLASTIC (42507-006-50)

Ingredients (1)

aspirin (81 mg/1)

Linked Drug Pages (1)

Low Dose Aspirin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "0915ffb3-ba95-4d9a-8bd1-c1401cc888dd", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0075450825404"], "unii": ["R16CO5Y76E"], "rxcui": ["308416"], "spl_set_id": ["98ab6fb7-c7e5-45ab-97c3-81d422f8a843"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Hy-Vee"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 BOX (42507-006-12)  / 120 TABLET, COATED in 1 BOTTLE, PLASTIC", "package_ndc": "42507-006-12", "marketing_end_date": "20270101", "marketing_start_date": "20251201"}, {"sample": false, "description": "500 TABLET, COATED in 1 BOTTLE, PLASTIC (42507-006-50)", "package_ndc": "42507-006-50", "marketing_end_date": "20270101", "marketing_start_date": "20251201"}], "brand_name": "Low Dose Aspirin", "product_id": "42507-006_0915ffb3-ba95-4d9a-8bd1-c1401cc888dd", "dosage_form": "TABLET, COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "42507-006", "generic_name": "Aspirin", "labeler_name": "Hy-Vee", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Low Dose Aspirin", "active_ingredients": [{"name": "ASPIRIN", "strength": "81 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_end_date": "20270101", "marketing_start_date": "20251010"}